Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The role of autophagy in cardiovascular pathology
Damián Gatica, Mario Chiong, Sergio Lavandero, et al.
Cardiovascular Research (2021) Vol. 118, Iss. 4, pp. 934-950
Open Access | Times Cited: 65

Showing 1-25 of 65 citing articles:

Critical Reanalysis of the Mechanisms Underlying the Cardiorenal Benefits of SGLT2 Inhibitors and Reaffirmation of the Nutrient Deprivation Signaling/Autophagy Hypothesis
Milton Packer
Circulation (2022) Vol. 146, Iss. 18, pp. 1383-1405
Open Access | Times Cited: 243
Mitophagy in cardiovascular diseases: molecular mechanisms, pathogenesis, and treatment
Amir Ajoolabady, Mario Chiong, Sergio Lavandero, et al.
Trends in Molecular Medicine (2022) Vol. 28, Iss. 10, pp. 836-849
Open Access | Times Cited: 119
Interaction of Cardiovascular Nonmodifiable Risk Factors, Comorbidities and Comedications With Ischemia/Reperfusion Injury and Cardioprotection by Pharmacological Treatments and Ischemic Conditioning
Péter Ferdinandy, Ioanna Andreadou, Gary F. Baxter, et al.
Pharmacological Reviews (2022) Vol. 75, Iss. 1, pp. 159-216
Open Access | Times Cited: 84
Vascular remodelling in cardiovascular diseases: hypertension, oxidation, and inflammation
Justyna Totoń‐Żurańska, T. Mikołajczyk, Blessy Saju, et al.
Clinical Science (2024) Vol. 138, Iss. 13, pp. 817-850
Closed Access | Times Cited: 25
Chemotherapy-induced cardiotoxicity: a new perspective on the role of Digoxin, ATG7 activators, Resveratrol, and herbal drugs
Hany Akeel Al-Hussaniy, Ali Hikmat Alburghaif, Zahraa Alkhafaje, et al.
Journal of Medicine and Life (2023) Vol. 16, Iss. 4, pp. 491-500
Open Access | Times Cited: 30
Understanding Sorafenib-Induced Cardiovascular Toxicity: Mechanisms and Treatment Implications
Jue Li, Lusha Zhang, Teng Ge, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 829-843
Open Access | Times Cited: 11
Role and molecular mechanisms of SGLT2 inhibitors in pathological cardiac remodeling (Review)
B K Chen, Jing Guo, Ye Hongmei, et al.
Molecular Medicine Reports (2024) Vol. 29, Iss. 5
Open Access | Times Cited: 9
Roles and mechanisms of quercetin on cardiac arrhythmia: A review
Yutong Zhou, Wendong Suo, Xinai Zhang, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113447-113447
Open Access | Times Cited: 37
Hypoxic extracellular vesicles from hiPSCs protect cardiomyocytes from oxidative damage by transferring antioxidant proteins and enhancing Akt/Erk/NRF2 signaling
Sylwia Bobis‐Wozowicz, Milena Paw, Michał Sarna, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Nanomaterials-based imaging diagnosis and therapy of cardiovascular diseases
Zhong Yang, Xueping Zeng, Yuling Zeng, et al.
Nano Today (2022) Vol. 45, pp. 101554-101554
Closed Access | Times Cited: 25
SGLT inhibitors for improving Healthspan and lifespan
James H. O’Keefe, Robert Weidling, Evan L. O’Keefe, et al.
Progress in Cardiovascular Diseases (2023) Vol. 81, pp. 2-9
Open Access | Times Cited: 15
Mitochondria and the Repurposing of Diabetes Drugs for Off-Label Health Benefits
Joyce Yip, Grace Shu Hui Chiang, I Lee, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 1, pp. 364-364
Open Access
Acrylamide Induces Antiapoptotic Autophagy and Apoptosis by Activating PERK Pathway in SH-SY5Y Cells
Yiqi Wang, Ying Liu, Xing Zhang, et al.
Toxics (2025) Vol. 13, Iss. 1, pp. 41-41
Open Access
Antigen Presentation by Graft Myofibroblasts Leads to Murine Heart Transplantation Rejection through the Autophagy Signaling Pathway
Weihua Gong, Zelai Wu, Bixian Luo, et al.
(2025)
Closed Access
The Mechanism of Acupuncture Regulating Autophagy: Progress and Prospect
Jing He, Min He, Mengmeng Sun, et al.
Biomolecules (2025) Vol. 15, Iss. 2, pp. 263-263
Open Access
Neurodegenerative diseases and neuroinflammation-induced apoptosis
Shi Huang, Yaxin Lu, Wenjun Fang, et al.
Open Life Sciences (2025) Vol. 20, Iss. 1
Open Access
The ER-phagy receptor FAM134B is targeted by Salmonella Typhimurium to promote infection
Damián Gatica, Reham M. Alsaadi, Rayan El Hamra, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Traditional Chinese medicine compounds modulate signaling pathways to improve cardiac-related pathology
Luwen Zhang, Wei Wang, Xincan Liu, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
The gut microbiota metabolite trimethylamine N-oxide promotes cardiac hypertrophy by activating the autophagic degradation of SERCA2a
Dongyu Lei, Yi Liu, Yuan Liu, et al.
Communications Biology (2025) Vol. 8, Iss. 1
Open Access
Histone deacetylase 6 inhibition attenuates pathological cardiac hypertrophy by promoting autophagy through MAP1LC3B ubiquitination
Jiayu Yao, Xiaoou Sun, YOU-SHENG CHEN, et al.
The Journal of Pathology (2025)
Closed Access
How Cells Deal with the Fluctuating Environment: Autophagy Regulation under Stress in Yeast and Mammalian Systems
Yuchen Lei, Yuxiang Huang, Xin Wen, et al.
Antioxidants (2022) Vol. 11, Iss. 2, pp. 304-304
Open Access | Times Cited: 21
Diosmetin Protects against Cardiac Hypertrophy via p62/Keap1/Nrf2 Signaling Pathway
Yingying Guo, Dan Li, Xian-feng Cen, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-14
Open Access | Times Cited: 20
Atg8–PE protein-based in vitro biochemical approaches to autophagy studies
Xue Huang, Jia Yao, Lu Liu, et al.
Autophagy (2022) Vol. 18, Iss. 9, pp. 2020-2035
Open Access | Times Cited: 16
Hydrogen inhalation enhances autophagy via the AMPK/mTOR pathway, thereby attenuating doxorubicin-induced cardiac injury
Tianjiao Ma, Lei Yang, Bin‐Mei Zhang, et al.
International Immunopharmacology (2023) Vol. 119, pp. 110071-110071
Closed Access | Times Cited: 10
LUBAC promotes angiogenesis and lung tumorigenesis by ubiquitinating and antagonizing autophagic degradation of HIF1α
Ying Jin, Yazhi Peng, Jie Xu, et al.
Oncogenesis (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top